QSAR study of benzothiazole derivatives as p56lck inhibitors

Letters in Drug Design and Discovery

Volumn 3, Issue 8, 2006, Pages 550-560

  Badiger, Aravind M ^a   Noolvi, Malleshappa N ^b   Nayak, P Vasudeva ^c  

^a KLE College of Pharmacy   (India)

^b JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

^c KUVEMPU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE INHIBITOR; T LYMPHOCYTE RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CELL ACTIVATION; COMPUTER PROGRAM; CORRELATION COEFFICIENT; DRUG DESIGN; DRUG STRUCTURE; ENZYME INHIBITION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; THEORETICAL MODEL;

EID: 33749609297     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006778194664     Document Type: Article

References (22)

1. Marth, J.D.; Peet, R.; Krebs, E.G.; Perlmutter, R.M. Cell, 1985, 43, 393-404.
2. Sefton, B.M. Oncogene, 1991, 6, 683-686.
3. Peri, K.G.; Gervais, F.G.; Weil, R.; Davidson, D.;Gish, G.D.; Veillette, A. Oncogene, 1993, 8, 2765-2772.
4. Chan, A. C.; Desai, D. M.; Weiss, A. Ann. Rev. Immunol., 1994, 12, 555-592.
5. Penninger, J.M.; Wallace, V. A.; Kishihara, K.; Mak, T. Immunol. Rev., 1993, 135, 183-214.
6. Perlmutter, R.M.; Levin, S.D.; Appleby M.W.; Anderson, S.J.; Alberolaila, J. Ann. Rev. Immunol., 1993, 11, 451-499.
7. Veillette, A.; Bookman M.A.; Horak, E.M.; Sameulson, L.E.; Bolen, J.B. Nature 1989, 338, 257-259.
8. Broadbridge R.J.; Sharma R.P. Curr. Drug Targets, 2000, 1, 365-386.
9. Al-Obeidi, F.A.; Wu, J.J.;Lam, K.S. Biopolymers (Pept.Sci), 1998, 47, 197-223.
10. McCracken, S,; Kim, C.S.; Xu, Y,; Minden M,; Miyamoto, N.G. Oncogene 1997, 15, 2929-2937.
11. Botfield, M.C.; Green, J.; Ann. Rep.Med.Chem., 1995, 30, 227-237.
12. Molina, T.J.; Kishihara, K.; Siderovski, D. P.; vanEwijk, W.; Narendra, A.; Timms, E.; Wakeham, A.; Paige, C. J.; Hartman, K-U.; Veillette, A.; Davison, D.; Mark, K. W. Nature 1992, 357, 161.
13. Jagabandhu, D.; James, L.; Robert, V.; Moquin,; Zhongqi, S.; Steven, H.; Spergel,; John, W.; Arthur, M.; Doweyko.; Henry, F.; DeFex,; Qiong, F.; Suhong, P.; Sidney, P.; Ding, R. S.; Gary, L.; Schieven.; Joel, C. B.; Bioorg. Med. Chem. Lett. 2003, 13, 2145-2149.
14. Kashiyama, E.; Hutchinson, I.; Chua, M. S.; Stinson, S. F.; Phillips, L. R.; Kaur, G.; Sausville, E. A.; Bradshaw, T. D.; Westwell, A. D.; Stevens, M. F. J. Med. Chem. 1999, 42, 4172-84.
15. Jagabandhu, Das,; Robert, V.; Moquin,; James Lin,; Chunjian, Liu,; Arthur, M.; Doweyko,; Henry, F.; DeFex,; Qiong, Fang,; Suhong, Pang,; Sidney, Pitt,; Ding Ren Shen,; Gary, L.; Schieven,; Joel C.; Barrish,; John, Wityak, Bioorg.Med.Chem.Lett. 2003, 13, 2587-2590.
16. Jure. Z.; Marjana, N. Analytica Chemica Acta, 1999, 388, 243-250.
17. Paul, L. J. Mol. Graphics Mod. 2000, 18, 464-477.
18. Scott, A.; Wildman.; Gordon, M.; Crippen. J. Mol. Graphics Mod. 2002, 21, 161-170.
19. Yaqiu, C.; Dezhao, C.; Chunyan, H.; Shangxu, H. Chemometrics Intelligent Laboratory Systems, 1999, 45, 267-276.
20. Hoskuldsson, A. J. Chemometrics, 1988, 2, 211-228.
21. Engh, R.; Bossemeyer, D. Pharmacol. Thera., 2002, 93, 99-111.
22. Thakur A.; Viswakarma S.; Thakur M. Bioorg. Med. Chem, 2004, 12, 1209-1214.